Loading...
NPI 1093294746 · Tomball, TX · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Graham Tomball LLC is a clinical medical laboratory provider located in Tomball, Texas. This profile covers 26 Medicare and 35 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Graham Tomball LLC |
| Address | 1101 Alma St Ste 104 |
| City | Tomball |
| State | TX |
| ZIP | 77375 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | August 13, 2018 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $900.6K |
| Medicaid | $386.2K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
26 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 7,670 | $30 | $260.7K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 2,400 | $70 | $177.5K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 2,030 | $30 | $68.8K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 2,210 | $30 | $55.3K |
| 87631 | The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,… | 340 | $140 | $47.3K |
| 87556 | The lab analyst performs a test for Mycobacterium tuberculosis using amplified nucleic acid probe technique. Mycobacteria tuberculosis are sometimes called acid fast bacteria because of the special… | 530 | $40 | $21.5K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 610 | $30 | $20.7K |
| 87496 | The lab analyst performs a test for cytomegalovirus, or CMV, using amplified nucleic acid probe technique. CMV may cause severe illness in newborns and immunocompromised patients. | 610 | $30 | $20.7K |
| 87640 | The lab analyst performs the technical lab test to look for Staphylococcus aureus nucleic acid using an amplified probe technique. | 600 | $30 | $20.5K |
| 87529 | The lab analyst performs a test for Herpes simplex virus, HSV, using amplified nucleic acid probe technique. HSV causes clusters of blisters, or vesicles, on different parts of the body and spreads… | 540 | $30 | $18.4K |
Showing 1–10 of 26
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 26 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
26 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 87798 | 41 | 300 | 790 | $30 | $265.1K |
| 87631 | 14 | 90 | 50 | $140 | $90.1K |
| 87481 | 43 | 270 | 150 | $30 | $68.8K |
| 87498 | 11 | 30 | 120 | $30 | $45.9K |
| 87529 | 10 | 60 | 90 | $30 | $43.6K |
| 87541 | 13 | 40 | 140 | $30 | $40.8K |
| U0004 | 3 | 20 | 50 | $70 | $40.4K |
| 87486 | 15 | 60 | 90 | $30 | $32.7K |
| 87581 | 14 | 70 | 80 | $30 | $32.2K |
| 87556 | 5 | 20 | 120 | $40 | $27.4K |
Showing 1–10 of 26
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
35 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 2,780 | $40 | $122.1K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 1,330 | $60 | $83.9K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 1,140 | $20 | $22.7K |
| 87631 | The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,… | 220 | $100 | $21.7K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 1,000 | $20 | $20.9K |
| 87496 | The lab analyst performs a test for cytomegalovirus, or CMV, using amplified nucleic acid probe technique. CMV may cause severe illness in newborns and immunocompromised patients. | 680 | $10 | $9.4K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 680 | $10 | $8.9K |
| 87640 | The lab analyst performs the technical lab test to look for Staphylococcus aureus nucleic acid using an amplified probe technique. | 570 | $20 | $8.5K |
| 87651 | The lab analyst performs a test for the bacteria Streptococcus, group A, using amplified nucleic acid probe technique. Strep A commonly causes acute pharyngitis, or strep throat. | 570 | $10 | $7.4K |
| 87653 | The lab analyst performs a test for Streptococcus, group B, using amplified nucleic acid probe technique. The amplified probe provides a rapid means to assess colonization by Streptococcus, group B,… | 580 | $10 | $6.9K |
Showing 1–10 of 35
How this provider's Medicaid billing volume and revenue compare to other Texas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Texas median
35 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 81408 | The lab analyst performs the technical lab test to complete one of the specific genetic analyses listed in this Tier 2, Level 9 molecular pathology code. | 19 | 40 | 100 | $230 | $335.3K |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 131 | 160 | 200 | $280 | $321.8K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 35 | 100 | 470 | $50 | $319.1K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 52 | 240 | 420 | $30 | $296.8K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 155 | 290 | 410 | $20 | $225K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 120 | 300 | 410 | $20 | $223.4K |
| 87631 | The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,… | 64 | 140 | 180 | $60 | $215.9K |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 76 | 150 | 320 | $20 | $184K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 109 | 260 | 640 | $20 | $137.2K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 58 | 170 | 440 | $20 | $93.6K |
Showing 1–10 of 35
Other providers in the same ZIP code as Graham Tomball LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Entramed, Inc | TX | Parenteral & Enteral Nutrition Supplies (DME) | $0 | $36.9M |
| Bva United LLC | TX | Ambulatory Surgical Clinic/Center | $4.7M | $0 |
| Ahmad Aslam | TX | Cardiovascular Disease Physician | $1.9M | $0 |
| Elite Medical Laboratory Solutions LLC | TX | Clinical Medical Laboratory | $83.7K | $1M |
| Waqar Khan | TX | Cardiovascular Disease Physician | $846.2K | $0 |
| George Valdez | TX | Family Medicine Physician | $835.7K | $0 |
| Penner Schraudenbach | TX | Urology Physician | $696.6K | $0 |
| Steven Sukin | TX | Urology Physician | $577.6K | $0 |
| Harold Wills | TX | Internal Medicine Physician | $495.7K | $0 |
| Alexander Trujillo | TX | Interventional Cardiology Physician | $465.5K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.